Evidence map›Paper›PMID 27096545›Full record

ArticlePhotochemistry and photobiology2016

Promotion of Proapoptotic Signals by Lysosomal Photodamage: Mechanistic Aspects and Influence of Autophagy.

David Kessel, Conor L Evans

Abstract read
In one paragraph

Article in Photochemistry and photobiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Determinants of Photodynamic Therapy Resistance in Cancer Cells.International journal of molecular sciences · 2024
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Photodynamic Therapy: A Brief History.Journal of clinical medicine · 2019
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

David KesselDepartment of Pharmacology, Wayne State University, Detroit, MI.
Conor L EvansWellman Center for Photomedicine, Harvard Medical School Massachusetts General Hospital, Boston, MA.

Funding

Subcellular targets and PDT-induces cell deathR01CA023378 · NCI · WAYNE STATE UNIVERSITY · PI KESSEL, DAVID HARRY · 1985 to 2013
$3.3M
Imaging and Overcoming Hypoxia-Induced Resistance in Metastatic Ovarian CancerDP2OD007096 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI EVANS, CONOR LEE · 2010 to 2010
$2.7M
NCI NIH HHS R01 CA023378NIH HHS DP2 OD007096
6 · The paper itself

Abstract

Prior studies demonstrated that a low level (LD10-15 ) of lysosomal photodamage can sensitize cells to the apoptotic death that results from subsequent mitochondrial photodamage. We have proposed that this process occurs via a calpain-catalyzed cleavage of the autophagy-associated protein ATG5 to form a proapoptotic fragment. In this report, we provide evidence for the postulated ATG5 cleavage and show that the sequential photodynamic therapy (PDT) protocol can also partly overcome the adverse effect of hypoxia on the initiation of apoptosis. While autophagy can offer cytoprotection after mitochondrial photodamage, this does not appear to apply when lysosomes are the target. This may account for the ability of very low PDT doses directed at lysosomes to evoke ATG5 cleavage. The resulting proapoptotic effect overcomes intrinsic cytoprotection from mitochondrial photodamage along with a further stimulation of phototoxicity.

Indexed as

AnimalsApoptosisAutophagyAutophagy-Related Protein 5Cell Line, TumorCell SurvivalLightLysosomesMicePhotosensitizing AgentsPorphyrinsAtg5 protein, mouseAutophagy-Related Protein 5Photosensitizing AgentsPorphyrinsTalaporfin

Identifiers

PMID27096545
PMCPMC4961560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.